Skip to main content
HSIC logo

Henry Schein Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Distribution

Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

Did you know?

Carries 22.0x more debt than cash on its balance sheet.

Current Price

$78.22

+0.14%

GoodMoat Value

$235.74

201.4% undervalued
Profile
Valuation (TTM)
Market Cap$9.21B
P/E23.14
EV$12.05B
P/B2.84
Shares Out117.72M
P/Sales0.70
Revenue$13.18B
EV/EBITDA12.68

Henry Schein Inc (HSIC) Financial Statements

GoodMoat Analysis

Based on data as of March 26, 2026

Henry Schein's financial profile presents a mixed picture for a value investor. The company generates a healthy free cash flow yield and maintains adequate profitability, but its low profit margins, high debt load, and modest growth rate are significant quality concerns.

Read full analysis
Henry Schein's financial quality, assessed through the GoodMoat framework, shows several areas of weakness. The company's 3.0% profit margin and 5.0% operating margin are low, failing to meet the high-margin thresholds typical of a quality business. This is a critical point, as low margins offer little buffer against operational challenges. On a more favourable note, the 6.0% free cash flow (FCF) yield is strong, indicating the business is converting earnings to cash effectively, which supports the framework's FCF criterion. However, the balance sheet is a notable weakness. A Debt/Equity ratio of 1.06 indicates significant leverage, far exceeding the framework's preference for a net cash position and a Debt/EBITDA under 1.0x. This elevates financial risk. Growth assessment reveals a modest 7.7% YoY revenue increase, which is below the double-digit, sustainable growth sought for high-quality compounders. The combination of low margins, high debt, and single-digit growth suggests the business operates in a competitive, low-moat environment with limited pricing power and efficiency advantages. While cash generation is solid, the overall financial profile is more indicative of an adequate, rather than a high-quality, enterprise from a value investing perspective. Analysis based on data as of 2024-05-15.

HSIC Financial Data

EBITDA$985.00M
Revenue (TTM)$13.18B
Gross Profit (TTM)$4.11B
Gross Margin
Operating Margin4.95%
ROE12.27%
ROA3.55%
Debt/Equity1.06
Current Ratio1.38
FCF$521.00M
FCF Yield5.66%
Piotroski F-Score
Rev/Share (TTM)$111.99
50-Day MA$76.93
200-Day MA$72.49
Shares Outstanding0.12B

HSIC Computed Insights

FCF$521.00M
FCF Growth Rate-1.71%
EPS Growth (CAGR)-8.87%
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

HSIC Financial Statements & Data

Henry Schein Inc (HSIC) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Henry Schein Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $13.18B. Gross profit (TTM) is $4.11B. EBITDA is $985.00M. Earnings per share (EPS) is $3.27. The P/E ratio is 23.14. Market capitalization is $9.21B.

Free cash flow (FCF) is $521.00M. FCF growth rate is -1.71%. EPS growth CAGR is -8.87%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Henry Schein Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.